SE0200301D0 - Thio-carbostyril derivative - Google Patents

Thio-carbostyril derivative

Info

Publication number
SE0200301D0
SE0200301D0 SE0200301A SE0200301A SE0200301D0 SE 0200301 D0 SE0200301 D0 SE 0200301D0 SE 0200301 A SE0200301 A SE 0200301A SE 0200301 A SE0200301 A SE 0200301A SE 0200301 D0 SE0200301 D0 SE 0200301D0
Authority
SE
Sweden
Prior art keywords
thio
carbostyril derivative
oxides
disease
dyskinesias
Prior art date
Application number
SE0200301A
Other languages
Swedish (sv)
Inventor
Haakan Wikstroem
Durk Dijkstra
Original Assignee
Axon Biochemicals Bv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Axon Biochemicals Bv filed Critical Axon Biochemicals Bv
Priority to SE0200301A priority Critical patent/SE0200301D0/en
Publication of SE0200301D0 publication Critical patent/SE0200301D0/en
Priority to PCT/SE2003/000164 priority patent/WO2003064393A1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/20—Oxygen atoms
    • C07D215/22—Oxygen atoms attached in position 2 or 4
    • C07D215/227—Oxygen atoms attached in position 2 or 4 only one oxygen atom which is attached in position 2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/36—Sulfur atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic System
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6564—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having phosphorus atoms, with or without nitrogen, oxygen, sulfur, selenium or tellurium atoms, as ring hetero atoms
    • C07F9/6581—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having phosphorus atoms, with or without nitrogen, oxygen, sulfur, selenium or tellurium atoms, as ring hetero atoms having phosphorus and nitrogen atoms with or without oxygen or sulfur atoms, as ring hetero atoms
    • C07F9/6584—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having phosphorus atoms, with or without nitrogen, oxygen, sulfur, selenium or tellurium atoms, as ring hetero atoms having phosphorus and nitrogen atoms with or without oxygen or sulfur atoms, as ring hetero atoms having one phosphorus atom as ring hetero atom
    • C07F9/65842—Cyclic amide derivatives of acids of phosphorus, in which one nitrogen atom belongs to the ring

Abstract

The novel thio-carbostyril derivative 7-{4-[4-(2,3-Dichloro-phenyl)-piperazin-1-yl]-butoxy}-3,4-dihydro-1H-quinoline-2-thione, its N-oxides and the N-oxides of Aripiprazole and salts thereof are useful agents for treating schizophrenia, Huntington's disease and dyskinesias in Parkinson's disease.
SE0200301A 2002-02-01 2002-02-01 Thio-carbostyril derivative SE0200301D0 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
SE0200301A SE0200301D0 (en) 2002-02-01 2002-02-01 Thio-carbostyril derivative
PCT/SE2003/000164 WO2003064393A1 (en) 2002-02-01 2003-01-31 Thio-carbostyril derivative, its n-oxides and the n-oxides of aripiprazole

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE0200301A SE0200301D0 (en) 2002-02-01 2002-02-01 Thio-carbostyril derivative

Publications (1)

Publication Number Publication Date
SE0200301D0 true SE0200301D0 (en) 2002-02-01

Family

ID=20286844

Family Applications (1)

Application Number Title Priority Date Filing Date
SE0200301A SE0200301D0 (en) 2002-02-01 2002-02-01 Thio-carbostyril derivative

Country Status (2)

Country Link
SE (1) SE0200301D0 (en)
WO (1) WO2003064393A1 (en)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7115587B2 (en) 2002-08-20 2006-10-03 Bristol-Myers Squibb Company Aripiprazole complex formulation and method
AU2008239841B2 (en) * 2007-04-12 2013-07-18 Teva Pharmaceuticals International Gmbh N-oxide and/or di-N-oxide derivatives of dopamine receptor stabilizers/modulators displaying improved cardiovascular side-effects profiles
HUP0700353A2 (en) * 2007-05-18 2008-12-29 Richter Gedeon Nyrt Metabolites of (thio)carbamoyl-cyclohexane derivatives
AU2008254585B2 (en) 2007-05-21 2013-09-26 Reviva Pharmaceuticals, Inc. Compositions, synthesis, and methods of using quinolinone based atypical antipsychotic agents
US7875610B2 (en) 2007-12-03 2011-01-25 Richter Gedeon Nyrt. Pyrimidinyl-piperazines useful as D3/D2 receptor ligands
US8207163B2 (en) 2008-05-27 2012-06-26 Reviva Pharmaceuticals, Inc. Compositions, synthesis, and methods of using piperazine based antipsychotic agents
AP2975A (en) 2008-07-16 2014-09-30 Richter Gedeon Nyrt Pharmaceutical formulations containing dopamine receptor ligands
HU230067B1 (en) 2008-12-17 2015-06-29 Richter Gedeon Nyrt Novel piperazine salt and preparation method thereof
HUP0800766A2 (en) 2008-12-18 2010-11-29 Richter Gedeon Vegyeszet Process for the preparation of piperazine derivatives
HUP0800765A2 (en) 2008-12-18 2010-11-29 Richter Gedeon Nyrt A new process for the preparation of piperazine derivatives and their hydrochloric salts
US8575185B2 (en) 2009-02-26 2013-11-05 Reviva Pharmaceuticals, Inc. Compositions, synthesis, and methods of utilizing quinazolinedione derivatives
US9012476B2 (en) 2011-12-08 2015-04-21 IVAX International GmbH Hydrobromide salt of pridopidine
CN104470585A (en) 2012-04-04 2015-03-25 爱华克斯国际有限公司 Pharmaceutical compositions for combination therapy
US11274087B2 (en) 2016-07-08 2022-03-15 Richter Gedeon Nyrt. Industrial process for the preparation of cariprazine
US11547707B2 (en) 2019-04-10 2023-01-10 Richter Gedeon Nyrt. Carbamoyl cyclohexane derivatives for treating autism spectrum disorder

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5006528A (en) * 1988-10-31 1991-04-09 Otsuka Pharmaceutical Co., Ltd. Carbostyril derivatives

Also Published As

Publication number Publication date
WO2003064393A1 (en) 2003-08-07

Similar Documents

Publication Publication Date Title
SE0200301D0 (en) Thio-carbostyril derivative
MA28010A1 (en) PIPERAZINE DERIVATIVES AND THEIR USE AS THERAPEUTIC AGENTS
ATE312831T1 (en) QUINOLINE DERIVATIVES AND THEIR USE AS ANTIBACTERIAL ACTIVES
RS51903B (en) Aripiprazole complex formulation and method
BRPI0407454A (en) Pyrazoles and methods of preparing and using them
EE200100167A (en) 4-amino-substituted 2-substituted 1,2,3,4-tetrahydroquinolines as CETP inhibitors
CH1175401H1 (en) Piperazine derivatives useful as CCR5 antagonists
BRPI0411743A (en) method and compositions for treating amyloid-related diseases
SG170785A1 (en) Benzothiazoles having histamine h3 receptor activity
ATE475418T1 (en) O-METHYLATED RAPAMYCIN DERIVATIVES FOR REDUCING OR PREVENTING LYMPHOPROLIFERATIVE DISEASES
AU2002344951A1 (en) Substituted piperazine and diazepanes as histamine h3 receptor agonists
EA200601391A1 (en) QUINOLINE DERIVATIVES FOR USE AS MYCOBACTERIAL INHIBITORS
BRPI0517797A (en) pentubstituted quinoline and isoquinoline derivatives, a process for their production and use as an inflammation inhibitor
ATE396174T1 (en) HYDROXYALKYLAMINE DERIVATIVES AS BETA-SECRETASE INHIBITORS AND THE USE THEREOF FOR THE TREATMENT OF ALZHEIMER'S DISEASE OR SIMILAR DISEASES
TR200103490T2 (en) Indolylpiperidine derivatives as antihistamine and antiallergic agents
ATE247726T1 (en) TARGETED ELECTROCHEMICAL REDUCTION OF HALOGENATED 4-AMINO-PICOLINIC ACIDS
PL373946A1 (en) Phenoxy piperidines for treating diseases such as schizophrenia and depression
DE60108626D1 (en) USE OF 5-THIO, SULFINYL AND SULFONYLPYRAZOLO 3,4-B] PYRIDINES AS CYCLIN-DEPENDENT KINASE INHIBITORS
ATE504293T1 (en) SUBSTITUTED CARBOSTYRIL DERIVATIVES AS 5-HT1A SUBTYPE AGONISTS FOR THE TREATMENT OF BIPOLAR DISORDER
EP1178796A4 (en) Salts of aminoimidazole carboxamide useful in the prevention and treatment of liver diseases
ATE251614T1 (en) PIPERAZINE DERIVATIVES AS NEUROKININ ANTAGONISTS
AU2003253149A1 (en) 3,4-dihydroquinolin-2-one, 5,6-fused oxazin-3-one, and 5,6-fused thiazin-3-one derivatives as matrix metalloproteinase inhibitors
EA200301101A1 (en) DERIVATIVES OF PIPERAZINE AND THEIR APPLICATION AS PDE4 INHIBITORS
DE60328931D1 (en) Aqueous preparations of perfluoropolyether phosphates and their use for the oil-repellent treatment of paper
BR0314461A (en) Process for the preparation of 2-aminomethylpyridine derivative